Thomas W. Lycan Jr., DO

About Me

Education: MD, University of Medicine and Dentistry of New Jersey, 2012
Residency: Internal Medicine, Wake Forest School of Medicine, 2015
Fellowship: Hematology and Oncology, Wake Forest School of Medicine, 2018
Board Certifications: American Board of Internal Medicine, Internal Medicine
Positions: Assistant Professor, Hematology and Oncology
Departments and Affiliations: Hematology and Oncology

Severe neurologic complications of immune checkpoint inhibitors: a single-center review.. Mancone S, Lycan T, Ahmed T, Topaloglu U, Dothard A, Petty WJ, Strowd RE. J. Neurol. 2018 May;
Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery.. Alphonse-Sullivan N, Taksler GB, Lycan T, Weaver KE, McTyre ER, Shenker RF, Page BR, Isom S, Johnson A, Munley MT, Laxton AW, Tatter SB, Watabe K, Chan MD, Ruiz J. Oncotarget. 2017 Nov; 8(60):101005-101011.
Impact of Curriculum Content on Resident Attitudes Towards Cancer Care.. Lycan T, Hansen K, Miller D. J Cancer Educ. 2017 Jun; 32(2):280-282.
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.. Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J. PLoS ONE. 2016; 11(10):e0164244.
Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: a controlled clinical trial.. Cheskin LJ, Mitchell AM, Jhaveri AD, Mitola AH, Davis LM, Lewis RA, Yep MA, Lycan TW. Diabetes Educ. ; 34(1):118-27.

View More Publications